Managing Anxiety in Pediatric Primary Care (MAPP)

Part of paid clinical trials in West Hartford, Connecticut.

Sponsor
UConn Health
Study ID
NCT06104904
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety
  • Anxiety Disorders

Eligibility Criteria

Sex
ALL
Age
6 Years - 17 Years
Healthy Volunteers
Accepted

Interventions

  • MAPP — BEHAVIORAL
    Behavioral intervention based on exposure therapy strategies.

Study Details

The goal of this clinical trial is to conduct a randomized controlled trial to enhance the capacity of pediatric primary care providers to assist their patients who struggle with anxiety. The study aims to refine and assess the feasibility of the Anxiety Action Plan (AxAP), a brief intervention to reduce pediatric anxiety, delivered by primary care providers (PCPs) in community pediatric primary care clinics. The goal of the AxAP is to enhance the capacity of PCPs to identify and intervene with anxious youth, which will enhance access to care in general and especially in locations with few mental health specialists. PCPs participating in this study will attend a training, administer the intervention to enrolled youth assigned to the MAPP condition, participate in coaching sessions, and fill out study questionnaires. Families participating in this study will complete evaluations with the study team, receive the intervention from their PCP (if assigned to the MAPP condition), and fill out study questionnaires. Researchers will compare the MAPP intervention to Enhanced Usual Care (EUC; consisting of videos, handouts, and other resources for anxiety reduction) to see the differences, if any, in child outcomes.

Key Dates

Start date
Nov 20, 2023
Status verified
Dec 2024
Primary completion
Jan 31, 2026
Completion
Jan 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Managing Anxiety in Pediatric Primary Care (MAPP)
    Participants receive approximately 4 sessions of a primary care provider-delivered intervention for reducing youth anxiety symptoms based on exposure therapy.
  • Placebo Comparator: Enhanced Usual Care (EUC)
    Participants receive a list of resources on how to reduce anxiety (e.g., videos, books, etc.).

Primary Outcome Measure

Clinical Global Impression Improvement scale [ Time Frame: Youth will be assessed at 2 months (post intervention) and 6 months after eligibility is established. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UConn HealthWest HartfordConnecticut06119
Golda S Ginsburg, PhD
[email protected]
860-523-3788
Grace L Imondi, BA
[email protected]
860-523-3788

Find similar trials in West Hartford, CT

By research site
UConn Health· West Hartford, CT

Related Studies